Trial
NCT01584466
Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
Schizophrenia
Intervention
Paliperidone
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-17